Posts
February 21 2025
Intelligent Bio Solutions Inc. announced the closing of its underwritten public offering in the amount of $3,000,000. EGS acted as counsel to the underwriter.
February 19 2025
Allurion Technologies, Inc. announced the closing of its registered direct offering in the amount of $6,100,000. EGS acted as counsel to the placement agent.
February 14 2025
WiSA Technologies, Inc. announced the closing of its registered direct offering in the amount of $5,400,000. EGS acted as counsel to the placement agent.
February 12 2025
Ilya Ross, a member of the Firm, was invited by NBI (National Business Institute) to present at their Marijuana Business Law In New York online seminar on March 18, 2025. Mr. Ross will present on two key topics: Banking and Financing for the Marijuana Industry and Legal Best Practices for Marijuana Product Packaging and Labeling. Click here for more information.
February 11 2025
RenovoRx, Inc. announced the closing of its firm commitment, underwritten public offering of common stock in the amount of $12,100,000. EGS acted as counsel to RenovoRx.
February 10 2025
Douglas Ellenoff was interviewed by Adam Torres with Mission Matters at this year’s Microcap Conference in Atlantic City, NJ. Doug discussed the current state of the microcap market and shared his perspective on emerging trends.
Click here to listen to the interview.
February 07 2025
Client Alert: Ending Illegal DEI and DEIA Discrimination and Preferences
On February 5, 2025, the United States Attorney General issued a Memo titled “Ending Illegal DEI and DEIA Discrimination and Preferences.” The Memo, among other things, includes a directive to the U.S. Department of Justice Civil Rights Division and the Office of Legal Policy to submit a report by March 1, 2025 on specific topics (“March Report”).
Click here to read the alert.
February 06 2025
Client Alert: Non-Profit Funding Update
On January 27, 2025, the Office of Management and Budget issued a Memo directing agencies to freeze all funding while a comprehensive analysis was conducted of all government funded programs. The purpose of the review was to evaluate whether the government funded programs are in line with the Executive Orders that have been issued.
Click here to read the alert.